Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: Clin Breast Cancer. 2019 Mar 6;19(4):225–235.e2. doi: 10.1016/j.clbc.2019.02.010

Figure 1.

Figure 1.

Genotyped single nucleotide polymorphisms in GATA3 and breast cancer outcomes in S8897 trial

P-values from log-rank test of single nucleotide polymorphisms with breast cancer outcomes, including disease-free survival (DFS) and overall survival (OS), are log10-transformed and plotted along with linkage disequilibrium map. Analyses were stratified by the treated and untreated group and results from each subgroup analysis are indicated by colors and shapes shown above. The lower and upper dashed lines indicate nominal significance threshold (0.05) and that after correction for multiple testing (0.001), respectively.